Drug intelligence / Profile preview

human ghrelin

Development stage
Phase 3
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

Ghrelin is a peptide hormone produced primarily in the stomach and released into the bloodstream. It is best known as the "hunger hormone" due to its potent stimulation of appetite and food intake. Ghrelin acts on the hypothalamus in the brain to increase hunger signals and also stimulates growth hormone (GH) release from the pituitary gland via activation of the growth hormone secretagogue receptor (GHS-R1a). Beyond appetite regulation, ghrelin plays roles in energy homeostasis, glucose metabolism (by inhibiting insulin secretion and promoting gluconeogenesis), fat storage promotion, cardiovascular protection (anti-inflammatory effects and improved heart failure outcomes), muscle preservation (prevents atrophy), bone formation modulation, immune system regulation (promotes anti-inflammatory cytokines), stress response modulation via HPA axis effects, reproductive function inhibition through suppression of gonadotropin-releasing hormone secretion, circadian rhythm regulation, memory/stress pathways in the brain, and potential involvement in cancer development/metastasis. Human recombinant or synthetic forms of ghrelin have been administered intravenously or subcutaneously for research purposes; pharmacokinetic studies show rapid clearance with a short half-life (~10–30 minutes). Clinical trials have explored its use for conditions such as cachexia but it is not an approved pharmaceutical product[2][6][9][8].

Brand names
Clinalfa
Other names
ghrelinlenomorelinacylated ghrelinunacylated ghrelin
02

Targets

GHSR (Growth hormone secretagogue receptor)

Beyond the preview

Go deeper on human ghrelin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human ghrelin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call